Related Experiment Videos
Acute myocardial infarction during pregnancy
David Verhaert1, Roland Van Acker
1UZ Gasthuisberg, Department of Cardiology, Leuven, Belgium. David.Verhaert@uz.kuleuven.ac.be
Acta Cardiologica
|July 17, 2004
Summary
A young woman experienced myocardial infarction during pregnancy despite no prior risk factors. Tocolytic therapy for preterm labor was a potential factor, highlighting the need for further research into pregnancy-related cardiac events.
Area of Science:
- Cardiology
- Obstetrics
- Maternal-Fetal Medicine
Background:
- Pregnancy significantly alters maternal hemodynamics, often underestimated.
- Preterm labor necessitates tocolytic therapy, with potential cardiovascular implications.
Observation:
- A 27-year-old primigravida without cardiac risk factors developed a non-Q wave myocardial infarction at 28 weeks gestation.
- Tocolytic agents, including ritodrine and nifedipine, were administered for preterm labor.
- Coronary angiography revealed no obstructive coronary artery disease.
Findings:
- Acute myocardial infarction can occur in pregnancy without traditional risk factors.
- Association between tocolytic therapy, particularly sympathomimetic agents, and myocardial infarction warrants further investigation.
- Pregnancy-induced hemodynamic changes complicate early diagnosis of cardiac events.
Implications:
- Further research is needed to clarify the role of tocolytic agents in pregnancy-associated myocardial infarction.
- Management strategies must balance maternal cardiac health with fetal well-being.
- Early diagnosis of myocardial infarction in pregnancy requires heightened clinical awareness.